Clinical Trials Directory

Trials / Terminated

TerminatedNCT03657082

Effects of PEP on IC During IT in Patients With COPD

Effects of Positive Expiratory Pressure on Inspiratory Capacity and Dyspnea in Patients With COPD During Exercise

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Academic / Other
Sex
All
Age
45 Years – 95 Years
Healthy volunteers
Not accepted

Summary

This study will investigate the effects of positive expiratory pressure (PEP) on hyperinflation in patients with chronic obstructive pulmonary disease (COPD). Inspiratory capacity (IC) is the primary outcome

Detailed description

This is a cross-over intervention assessing the effect of PEP on IC and dyspnea in patients with COPD performing an interval training (IT) session. IC will be measured before, during and immediately after the IT session. Each participant will receive perform IT sessions including either the use of a PEP of 10 cmH2O or a PEP of 1 cmH2O. The effects on IC and dyspnea on both PEP levels will be assessed.

Conditions

Interventions

TypeNameDescription
DEVICEPEP-10Bottle PEP with a water level of 10 cmH2O
DEVICEPEP-1Bottle PEP with a water level of 1 cmH2O

Timeline

Start date
2018-09-15
Primary completion
2021-12-30
Completion
2021-12-30
First posted
2018-09-04
Last updated
2024-05-08

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03657082. Inclusion in this directory is not an endorsement.